Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Epidemiology
-
2. Epidemiology of obesity
- Prof. Jacob Seidell
- Etiology and Causes
-
3. Metabolic, adipose tissue and muscle predictors of obesity
- Prof. Ian Macdonald
-
4. Neural control of food intake and energy balance
- Prof. Hans-Rudolf Berthoud
-
6. Dietary determinants of obesity
- Prof. Arne Astrup
-
7. Physical inactivity as a determinant of obesity
- Prof. Wim Saris
-
8. Environmental causes of obesity: sociocultural, built environment and economic factors
- Prof. Shiriki Kumanyika
-
9. The developmental origins of obesity
- Prof. David Barker
- Consequences of Obesity
-
10. Obesity, dyslipoproteinemia and inflammation
- Prof. Robert Eckel
-
11. Pathophysiology and management of obesity related hypertension
- Prof. Arya Sharma
-
12. Disorders of overeating
- Prof. Albert Stunkard
-
13. Obesity, weight loss and health-related quality of life
- Prof. Aila Rissanen
- Dr. Jarmo Kaukua
- Treatment Options
-
14. Lifestyle modification for weight control
- Prof. Thomas Wadden
-
15. Bariatric / obesity surgery
- Prof. Henry Buchwald
-
16. Can obesity be prevented in the current obesogenic environment?
- Prof. Boyd Swinburn
-
17. Pharmacotherapy for obesity: why it is needed
- Prof. Joe Proietto
-
18. Pharmacotherapy for obesity: hunger suppressors
- Prof. Joe Proietto
- Latest Developments in the Field
-
19. Body composition
- Dr. Steven Heymsfield
-
20. Adipose tissue metabolism and obesity
- Dr. Max Lafontan
-
21. Obesity, present and future therapies
- Prof. Sir Stephen Bloom
-
22. Energy expenditure in the lean and obese
- Prof. Dale Schoeller
-
23. Obesity and adiponectin
- Prof. Philipp Scherer
-
24. Ectopic fat: causes, consequences and treatment
- Prof. Steven Smith
-
25. Adipose-immune interactions in obesity
- Dr. Vishwa Dixit
-
26. Health benefits of intentional weight loss
- Prof. Xavier Pi-Sunyer
-
27. Childhood obesity: implications for current and future health
- Prof. Peter T. Katzmarzyk
- Archived Lectures - These lectures may not cover the latest advances in the field
-
29. Gastrointestinal peptides and food intake regulation
- Prof. Sir Stephen Bloom
-
30. Obesity and mortality: questions and controversy
- Prof. David Allison
-
31. Obesity, diabetes and the cluster of the metabolic syndrome
- Prof. Peter Wilson
-
33. Health economics of obesity: new insights
- Dr. Anne Wolf
-
34. Bariatric surgery: techniques and mechanisms of action
- Prof. Walter Pories
-
35. Childhood obesity: implications for future health
- Prof. Peter T. Katzmarzyk
Printable Handouts
Navigable Slide Index
- Introduction
- Medical complications of obesity
- Obesity is the primary risk factor for diabetes
- Age-adjusted prevalence of hypertension vs. BMI
- Metabolic syndrome: clinical identification
- Twin epidemics: parallels in prevalence
- Obesity and coronary heart disease mortality
- Intentional weight loss and its health benefits
- Data supporting life-style intervention
- Weight loss and cardiovascular risk
- US diabetes prevention program
- Study interventions
- Characteristics by treatment group assignment
- DPP: lifestyle intervention
- Dietary factors that affect energy intake
- Weight-Reducing diet - recommended nutrients
- DPP: effect of interventions on weight
- DPP: mean change in leisure physical activity
- DPP: cumulative incidence of diabetes
- Mean change in blood pressure
- Mean change in lipids (1)
- Mean change in lipids (2)
- Thrombogenic and inflammatory risk
- Mean change in TPA
- Mean change in fibrinogen
- Mean change in CRP
- CRP levels in obese postmenopausal women
- Finnish diabetes prevention study
- FDPS: goals of intervention
- FDPS: effect of interventions on weight
- FDPS: prevention of diabetes
- FDPS: changes in clinical and metabolic variables
- Hazard rate for diabetes and the change in weight
- DPP and FDPS conclusions
- LookAHEAD trial (1)
- Look AHEAD trial (2)
- Baseline characteristics of participants
- LookAHEAD interventions
- LookAHEAD: weight loss at 1-year
- LookAHEAD: fitness change at 1-year
- LookAHEAD: glycemia outcomes
- LookAHEAD: blood pressure outcomes
- LookAHEAD: lipid outcomes
- LookAHEAD: other outcomes
- LookAHEAD: conclusions
- Trials of hypertension prevention, phase II
- TOHP II: effect of intervention on weight
- TOHP II: mean change in blood pressure
- Effects of population-based BP reduction
- Effect of modest weight loss on cholesterol
- Effect of weight loss on HDL-C in type 2 diabetes
- Weight loss: mechanisms for improvement in risks
- Adipose tissue as endocrine cells
- Obesity as a therapeutic target for prevention
- Cancer incidence attributable to obesity
- All cause mortality
- Thank you
Topics Covered
- Medical complications of obesity
- Obesity is the primary risk factor for diabetes
- Age-adjusted prevalence of hypertension vs. BMI
- Metabolic syndrome: clinical identification
- Obesity and coronary heart disease mortality
- Data supporting life-style intervention
- Weight loss and cardiovascular risk
- US diabetes prevention program
- Study interventions
- DPP: lifestyle intervention
- Dietary factors that affect energy intake
- Weight-Reducing diet
- recommended nutrients
- Mean change in blood pressure
- Mean change in lipids
- Thrombogenic and inflammatory risk
- Mean change in TPA
- Mean change in fibrinogen
- Mean change in CRP
- Finnish diabetes prevention study
- Hazard rate for diabetes and the change in weight
- LookAHEAD trial
- Trials of hypertension prevention, phase II
- Effects of population-based BP reduction
- Effect of modest weight loss on cholesterol
- Adipose tissue as endocrine cells
- Obesity as a therapeutic target for prevention
- Cancer incidence attributable to obesity
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pi-Sunyer, X. (2009, May 31). Health benefits of intentional weight loss [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 21, 2025, from https://doi.org/10.69645/KYDT9407.Export Citation (RIS)
Publication History
- Published on May 31, 2009
Financial Disclosures
- Prof. Xavier Pi-Sunyer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.